PortViewPortView
GreenLight Biosciences logo

GreenLight Biosciences (GRNA) Stock Analysis

NASDAQHealthcareBiotechnology

$0.30-0.03%
1-year price historyRange $0.18 – $4.16
52-week range$0.30
$0.18$5.90

What GreenLight Biosciences does

GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings feature RNA-based innovations designed to protect honeybees and defend crops. Established in 2008, GreenLight Biosciences Holdings is based in Medford, Massachusetts.

Key metrics

Market cap
$45.43M
P/E (TTM)
-0.27
EPS (TTM)
$-1.12
Beta
1.44
Dividend yield
0.00%
Revenue / share
$0.05
50-day avg
$0.27
200-day avg
$0.85
52-week high
$5.90
52-week low
$0.18
CEO
Andrey Juan Zarur

ETFs linked to GRNA

Broad-market and Healthcare sector ETFs an investor holding GreenLight Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how GRNA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GRNA in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for GreenLight Biosciences?
GreenLight Biosciences trades under the ticker GRNA on NASDAQ.
Which exchange is GRNA listed on?
GRNA is listed on NASDAQ.
What sector does GreenLight Biosciences operate in?
GreenLight Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GRNA in a portfolio?
PortView shows GRNA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.